George Fulop and Needham - Free people check

(1 - 8 from 10

)

Panacos shares plummet 31% after drug trial - MarketWatch

Needham & Co. analyst George Fulop said he thinks the formulation problems will delay the launch of the drug, if approved, by six months to a ...

Data.com: George Fulop

Job: Vice President, Biotechnology and Life Sciences; City: New York; Company: Needham

Vertex …s Q Earnings Call Transcript | Seeking...

George Fulop - Needham. Yaron Werber - Citigroup. Howard Liang - Leerink Swann. Presentation. Operator. Good afternoon. My name is Todd ...

Google Groups: Deutsche Bank 32nd Annual Health Care Conference

: "Its pipeline of internally developed compounds makes Epix attractive at current prices," says George Fulop of Needham, who has a 12-month target of

Google Groups: NEEDHAM Analyst Rating Buy: Undervalued

: ... partnerships with Amgen and GlaxoSmithKline, and substantial upcoming news flow, we believe Epix shares are under-valued," wrote analyst George Fulop

George Fulop MD, Vice President, Biotechnology & Life Sciences Needham & Co . “Vical has a unique technology that caught my attention; they used DNA vaccines and address many conditions ranging from HIV to influenza and even avian flu. They have a unique technology that I think is promising and an alternative to ...

People
Forename "George" (62710)
Name "Fulop" (178)

sorted by relevance / date

Advanced Search

Search name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

George Fulop and Needham Free People Check

Panacos shares plummet 31% after drug trial - MarketWatch

Data.com: George Fulop

Vertex …s Q Earnings Call Transcript | Seeking...

Google Groups: Deutsche Bank 32nd Annual Health Care Conference

Google Groups: NEEDHAM Analyst Rating Buy: Undervalued

CEOCFO Analyst Interviews!

Needham & Co. on Vical Incorporated (VICL-NASDAQ ...www.ceocfointerviews.com › VICL-Analyst07

Profits from pain: Big Pharma and next-generation pain…s

All web results to the name "George Fulop"